Antacids Market by Formulation (Liquid, Powder, Tablet), Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents), Distribution Channel - Global Forecast 2024-2030
The Antacids Market size was estimated at USD 7.88 billion in 2023 and expected to reach USD 8.27 billion in 2024, at a CAGR 5.13% to reach USD 11.19 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antacids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antacids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antacids Market, highlighting leading vendors and their innovative profiles. These include Alardius Healthcare, Bayer AG, Biozenta Lifescience PVT LTD, Boehringer Sohn AG & Ko. KG, Cadila Pharmaceuticals Limited, GlaxoSmithKline PLC, GM Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Procter and Gamble Company, Sanofi-Aventis Groupe S.A., Torrent Pharmaceuticals Ltd., Uniroyal Biotech, and WellSpring Pharmaceutical Corporation.
Market Segmentation & Coverage
This research report categorizes the Antacids Market to forecast the revenues and analyze trends in each of the following sub-markets:
Formulation
Liquid
Acid Neutralizers
Hospital Pharmacy
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Antacids Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antacids Market?
- What are the technology trends and regulatory frameworks in the Antacids Market?
- What is the market share of the leading vendors in the Antacids Market?
- Which modes and strategic moves are suitable for entering the Antacids Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Antacids Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing population suffering from gastroesophageal reflux disease, or GERD due to unhealthy lifestyle choices and consumption of drugs resulting in acidity
- 5.1.1.2. Increasing information creating awareness about GERD
- 5.1.1.3. Sedentary and stressed lifestyle demanding antacids
- 5.1.2. Restraints
- 5.1.2.1. Availability of home remedies and other alternatives for acidity related issues
- 5.1.3. Opportunities
- 5.1.3.1. Development of more instantly effective and long lasting antacids
- 5.1.3.2. Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
- 5.1.4. Challenges
- 5.1.4.1. FDA drug recall due to significant health side effects associated with the antacids
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Antacids Market, by Formulation
- 6.1. Introduction
- 6.2. Liquid
- 6.3. Powder
- 6.4. Tablet
- 7. Antacids Market, by Drug Class
- 7.1. Introduction
- 7.2. Acid Neutralizers
- 7.3. H2 Antagonist
- 7.4. Promotility Agents
- 7.5. Proton Pump Inhibitor
- 8. Antacids Market, by Distribution Channel
- 8.1. Introduction
- 8.2. Hospital Pharmacy
- 8.3. Retail Pharmacy
- 9. Americas Antacids Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Antacids Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Antacids Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Alardius Healthcare
- 13.1.2. Bayer AG
- 13.1.3. Biozenta Lifescience PVT LTD
- 13.1.4. Boehringer Sohn AG & Ko. KG
- 13.1.5. Cadila Pharmaceuticals Limited
- 13.1.6. GlaxoSmithKline PLC
- 13.1.7. GM Pharmaceuticals, Inc.
- 13.1.8. Johnson & Johnson Services, Inc.
- 13.1.9. Novartis AG
- 13.1.10. Pfizer Inc.
- 13.1.11. Procter and Gamble Company
- 13.1.12. Sanofi-Aventis Groupe S.A.
- 13.1.13. Torrent Pharmaceuticals Ltd.
- 13.1.14. Uniroyal Biotech
- 13.1.15. WellSpring Pharmaceutical Corporation
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ANTACIDS MARKET RESEARCH PROCESS
- FIGURE 2. ANTACIDS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANTACIDS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANTACIDS MARKET DYNAMICS
- FIGURE 7. ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
- FIGURE 8. ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
- FIGURE 10. ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 12. ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ANTACIDS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook